Novartis AG Annual Shareholders Meeting Transcript
Good morning, shareholders. Ladies and gentlemen, I'd like to extend a very warm welcome to our 28th Annual General Meeting of Novartis AG. It's a great pleasure for me to be welcoming such a large number of you here to the St. Jakobshalle in Basel. I'd also like to welcome the members of the Board of Directors and the members of the Executive Committee who are with today. We also have the representatives of our auditors here. That's KPMG AG represented by the notary, Andrea Schmatz and Mr. Peter Andreas Zahn, who's the independent proxy. I hereby appoint Ms. Charlotte Pamer, Secretary of the Board of Directors, as keeper of the minutes. And as tellers, I appoint Mr. Thomas Aegerter from UBS, Ms. Alexandra (inaudible) from the (inaudible) Bank; and Ms. Olga Nieto from Citibank.
Today's Annual General Meeting was called by publication of the full agenda in the Swiss Commercial Gazette #26 dated the seventh of February 2024. Unless otherwise provided by law or the articles of incorporation, the Annual General Meeting we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |